A First-in-Human Single- and Multiple-Ascending Dose Study Evaluating Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Oral Nonpeptide GLP-1 Receptor Agonist in Healthy Subjects

Authors
Category Primary study
ConferenceDiabetes
Year 2022
This article has no abstract
Epistemonikos ID: a9bf6ad41cf4a2b0f03413965655f3ab80c18ddd
First added on: Dec 07, 2023